Mannkind (MNKD) Long-Term Investments (2021 - 2025)
Mannkind's (MNKD) quarterly Long-Term Investments came in at $5.0 million in Q4 2025, down 8.57% year-on-year from $5.5 million in Q4 2024, and down 80.89% on a QoQ basis from $26.2 million in Q3 2025.
Mannkind (MNKD) Long-Term Investments (2021 - 2025) Analysis & Trends
Mannkind (MNKD) has 5 years of Long-Term Investments data on file, last reported at $5.0 million in Q4 2025.
- On a quarterly basis, Long-Term Investments fell 8.57% year-over-year to $5.0 million in Q4 2025; TTM through Dec 2025 was $5.0 million, a 8.57% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 8.57% from the prior year.
- Long-Term Investments for Q4 2025 stood at $5.0 million, down from $26.2 million in the prior quarter.
- Over the last five years, Long-Term Investments for MNKD reached as high as $70.5 million in Q1 2022 and fell as low as $492000.0 in Q1 2023.
- Historically, Long-Term Investments has averaged $19.0 million across 5 years, with a median of $13.0 million in 2022.
- Across the five-year window, Long-Term Investments soared 4602.8% in 2022 and tumbled 99.3% in 2023, its largest moves.
- Year by year, Long-Term Investments stood at $56.6 million in 2021, then sank by 96.54% to $2.0 million in 2022, then surged by 264.86% to $7.2 million in 2023, then slipped by 23.38% to $5.5 million in 2024, then retreated by 8.57% to $5.0 million in 2025.
- Per Business Quant data, the three most recent Long-Term Investments figures were $5.0 million in Q4 2025, $26.2 million in Q3 2025, and $22.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.01 Mn |
| Sep 30, 2025 | 26.23 Mn |
| Jun 30, 2025 | 22.24 Mn |
| Mar 31, 2025 | 16.68 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Sep 30, 2024 | 16.80 Mn |
| Jun 30, 2024 | 13.40 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 7.16 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 492,000.00 |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 12.70 Mn |
| Jun 30, 2022 | 32.60 Mn |
| Mar 31, 2022 | 70.54 Mn |
| Dec 31, 2021 | 56.62 Mn |
| Sep 30, 2021 | 42.10 Mn |
| Jun 30, 2021 | 39.00 Mn |
| Mar 31, 2021 | 1.50 Mn |